This site is intended for healthcare professionals
Latest drug news
  • Home
  • /
  • News
  • /
  • 2019
  • /
  • 08
  • /
  • Royal Philips launches CE approved HeartStart Intr...
Drug news

Royal Philips launches CE approved HeartStart Intrepid monitor/defibrillator for cardiac arrest

Read time: 1 mins
Last updated:21st Aug 2019
Published:20th Aug 2019
Source: Pharmawand

Royal Philips announced the launch of the HeartStart Intrepid monitor/defibrillator with IntelliSpace Connect. Created to provide clinical and operational efficiencies at every stage of the emergency care continuum, the solution lets caregivers evaluate and treat patients during the most demanding medical emergencies in both pre-hospital and hospital settings.

The Philips HeartStart Intrepid monitor/defibrillator has received CE Mark approval and is available for sale in Europe and other select markets in Asia and Africa . A full range of monitoring capabilities and decision support tools let emergency staff quickly evaluate and treat patients in life-threatening situations. Enhanced connectivity between care settings helps to streamline communication and improve clinical workflow for caregivers, ultimately allowing them to provide patients with better care.

Learning Zones

The Learning Zones are an educational resource for healthcare professionals that provide medical information on the epidemiology, pathophysiology and burden of disease, as well as diagnostic techniques and treatment regimens.

Related news and insights